BAP1 Syndrome — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Delay capecitabine until at least 4 weeks after the last brivudine dose
Brivudine potently inhibits DPD and can cause fatal fluoropyrimidine toxicity. The capecitabine SmPC requires at least a four-week interval after brivudine; a normal germline DPYD test does not neutralise acquired enzyme inhibition. Intravenous fluorouracil shares the interaction, and empirical dose reduction is not an acceptable substitute for the waiting interval.
Reference: Capecitabine UK SmPC. https://www.medicines.org.uk/emc/product/14545/smpc